About This Research Study
Type 1 diabetes (T1D) is a disease where the body stops making insulin, a hormone that helps control blood sugar, leading to lifelong dependence on insulin therapy and careful blood sugar management. Tekton Research is conducting a clinical trial for an investigational insulin combination therapy. People with T1D who are currently receiving multiple daily insulin injections may be eligible to participate.
Eligible Participants…
- Must be age 18+
- Must be diagnosed with type 1 diabetes mellitus
- Must be taking multiple daily insulin injections
- Must NOT be taking medications for diabetes or obesity aside from insulin within the past 90 days
- May receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.